Neelima Chandra
Overview
Explore the profile of Neelima Chandra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agrahari V, Peet M, Chandra N, Ramalingam P, Gupta P, Jonnalagadda S, et al.
J Control Release
. 2024 Nov;
377:842-854.
PMID: 39592025
Pre-exposure prophylaxis (PrEP) has emerged as a prominent approach for the prevention of HIV infections. While the latest advances have resulted in effective oral and injectable product options, there are...
2.
Thurman A, Brache V, Cochon L, Ouattara L, Chandra N, Jacot T, et al.
PLoS One
. 2022 Oct;
17(10):e0275794.
PMID: 36215267
Multipurpose prevention technologies (MPTs), which prevent sexually transmitted infection(s) and unintended pregnancy, are highly desirable to women. In this randomized, placebo-controlled, phase I study, women used a placebo or tenofovir...
3.
Rochani A, Agrahari V, Chandra N, Singh O, McCormick T, Doncel G, et al.
Polymers (Basel)
. 2022 May;
14(9).
PMID: 35566897
This study explored the development of cross-linked gels to potentially provide a physical barrier to vaginal sperm transport for contraception. Two types of gels were formulated, a physically cross-linked iota-carrageenan...
4.
Demirel E, Sabouni R, Chandra N, Slayden O, Archer D
Reprod Sci
. 2021 Nov;
29(3):1001-1019.
PMID: 34796470
As a key mechanism in fibrinolysis and tissue remodeling, the plasminogen activator system has been suggested in the process of endometrial shedding and tissue remodeling. Previous studies have explored the...
5.
Gustin A, Thurman A, Chandra N, Schifanella L, Alcaide M, Fichorova R, et al.
Am J Obstet Gynecol
. 2021 Sep;
226(2):225.e1-225.e15.
PMID: 34560047
Background: Bacterial vaginosis-a condition defined by a shift from Lactobacillus dominance to a polymicrobial, anaerobic bacterial community-increases the risk of acquiring sexually transmitted infections and other complications of the female...
6.
Anderson S, Thurman A, Chandra N, Jackson S, Asin S, Rollenhagen C, et al.
Nutrients
. 2020 Oct;
12(10).
PMID: 33080839
While vitamin D insufficiency is known to impact a multitude of health outcomes, including HIV-1, little is known about the role of vitamin D-mediated immune regulation in the female reproductive...
7.
Thurman A, Cunningham T, Fichorova R, Herold B, Hillier S, Chandra N, et al.
Contraception
. 2019 Aug;
100(6):430-437.
PMID: 31442441
Objectives: To evaluate a lactic-acid-containing diaphragm gel (Contragel®) approved outside the United States for use with a silicone rubber diaphragm (Caya®). The study gel is being evaluated as a safer...
8.
Thurman A, Chandra N, Schwartz J, Brache V, Chen B, Asin S, et al.
AIDS Res Hum Retroviruses
. 2019 Apr;
35(9):853-864.
PMID: 30997816
Reproductive age women may choose to concurrently use topical antiretrovirals and hormonal contraceptives (HCs) to simultaneously prevent HIV-1 infection and unintended/mistimed pregnancy. There are conflicting data on the effect of...
9.
Zalenskaya I, Chandra N, Yousefieh N, Fang X, Adedipe O, Jackson S, et al.
J Clin Invest
. 2018 Sep;
128(10):4622-4638.
PMID: 30222141
Background: Injectable depot medroxyprogesterone acetate (DMPA) is one of the most popular contraception methods in areas of high HIV seroprevalence. Evidence is accumulating that use of DMPA might be associated...
10.
Thurman A, Schwartz J, Brache V, Chen B, Chandra N, Kashuba A, et al.
J Acquir Immune Defic Syndr
. 2018 Sep;
80(1):79-88.
PMID: 30212395
Objective: Endogenous and exogenous contraceptive hormones may affect mucosal pharmacokinetics (PKs) of topical antiretrovirals such as tenofovir. We present PK data from healthy women using tenofovir vaginal gel, at baseline...